• Front Matter R1-R14

• 1 Executive Summary 1-8

• 2 Histories of Pertussis and Rubella Vaccines 9-31

• 3 Methodologic Considerations in Evaluating the Evidence 32-64

• 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile Spasms, Hypsarrhythmia, Aseptic Meningitis, and Encephalopathy 65-124

• 5 Evidence Concerning Pertussis Vaccinces and Deaths Classified as Sudden Infant Death Syndrome (SIDS) 125-143

• 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions 144-186

• 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura 187-205

• Afterword on Research Needs 206-207

• Bibliography 208-282

• Glossary of Terms 283-292

• Appendix A: Strategies for Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines 293-319

• Appendix B: Pertussis and Rubella Vaccines: A Brief Chronology 320-332

• Appendix C: Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials 333-336

• Appendix D: Technical Details of Power Calculations and Meta-Analyses 337-346

• Appendix E: Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse Events After Pertussis Immunization 347-348

• Appendix F: Committee and Staff Biographies 349-354

• Index 355-367

" Appendix A: Strategies for Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines ." Adverse Effects of Pertussis and Rubella Vaccines . Washington, DC: The National Academies Press, 1991 .

Please select a format: